Dyslipidemia may also arise due to the reduced activity of liver lipoprotein lipase and hepatic triglyceride lipase enzymes, which are influenced by uremic toxins and high levels of apoprotein C-III (22, 44). Here, DDHD2 is linked to metabolic syndrome.